Search PubMed⌕ Search

Biomedical subjects

D D Tresch

Publications and source records attributed to D D Tresch.

59 records · Page 4Linked to original sources
PubMedDate not supplied

Diagnosis and management of myocardial ischemia (angina) in the elderly patient.

Coronary artery disease is a major problem in the elderly population. Approximately 60% of all acute myocardial infarctions in the United States occur in people 65 years or older, and 30% occur in persons older than 75 years. Morbidity and mortality are high in elderly patients who sustain a myocardial infarction. Due to the atypical presentation of myocardial ischemia and absence of classic symptoms, coronary artery disease may not be diagnosed in many of these patients until an acute myocardial infarction occurs. Early diagnosis of coronary artery disease and reduction of all coronary risk factors are beneficial in reducing future coronary events in older as well as in younger patients. Many studies have shown that anti-ischemic and acute myocardial infarction therapies have been underutilized in the elderly population. The principles of drug therapy for myocardial ischemia are the same as those for younger patients. Aggressive therapy, including early coronary angiography and revascularization, has been found to be as beneficial in high-risk, unstable older patients as in younger patients. Therapy should be individualized according to the patient's clinical condition. On the basis of current knowledge, elderly, high-risk patients with acute coronary syndromes may be treated with a combination of intensive medical therapy and early coronary angiography with revascularization.

Aged↗
PubMedDate not supplied

Management of acute myocardial infarction in the elderly.

Thrombolysis and other new therapies have proved beneficial in elderly patients with myocardial infarction, but are underused in this age group. Because elderly patients are at greater cardiac risk than younger patients, they have more to gain from treatment. However, these treatments may pose more risk for elderly patients. Physicians must constantly assess the elderly patient's risk status and make treatment decisions based on risk-benefit analysis.

Adrenergic beta-Antagonists↗